Susan D. Reed
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Susan D. Reed has a total of 500 co-authors. Here are the top co-authors by number of shared publications:
Katherine M. Newton
Kaiser Permanente Washington Health Research Institute, 1730 Minor Ave, Suite, 1360, Seattle, WA, USA
45 shared publicationsAndrea Z. LaCroix
Department of Family and Preventive Medicine, University of California-San Diego, La Jolla, CA
40 shared publicationsKatherine A. Guthrie
Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, WA
32 shared publications- Kristine E. Ensrud
Division of Epidemiology & Community Health, School of Public Health, University of Minnesota, Minneapolis, USA
23 shared publications Joseph C. Larson
Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA
20 shared publicationsEllen W. Freeman
Obstretrics and Gynecology, and Psychiatry, Perlman School of Medicine, University of Pennsylvania, Philadelphia, PA
18 shared publications
Latest Publications
- 17 December 2024
- Published by Wolters Kluwer Health in Menopause
- Vol. 32 (1) , 23-30
Menopause symptom burden and management across rural, suburban, and urban settings in a US population
Objective: The aim of this study was to compare menopause experience in rural, suburban, and urban-residing women. Methods: A 2019 online survey of US females queried respondents on menopause symptoms, resources, and treatments. Those ≥45 years of age and in late menopause transition or postmenopause were included in the analysis. Late menopause transition and postmenopause subgroups were stratified by rural, suburban, and urban residence, and age-weighted proportions for menopause symptoms and treatments were calculated and compared using chi-square tests. Results: A total of 1,531 respondents, 45% (n = 686) late menopause transition, mean age of 50.7 (SD 3.9) and 55% (n = 845) postmenopause, and mean age of 65.1 (SD 8.5) were included. More prevalent symptoms in late menopause transition rural residents were as follows: muscle aches and pains (urban: 49%, suburban: 49%, rural: 65%, P = 0.003), and panic attacks (urban: 18%, suburban: 24%, rural: 30%, P = 0.04). More prevalent symptoms in postmenopause rural residents were as follows: mood swings (urban: 18%, suburban: 14%, rural: 23%, P = 0.02), urinary incontinence (urban: 19%, suburban: 14%, rural: 23%, P = 0.02), and vaginal dryness (urban: 22%, suburban: 29%, rural: 37%, P = 0.004). Vasomotor symptom prevalence was high (71% late menopause transition, 20% postmeopause), but current menopause hormone therapy use was low (11% late menopause transition, 11% postmenopause) and did not differ by residence, despite differences in menopausal resources used. Conclusions: Rural women may experience greater burden of psychological and somatic menopause symptoms but not vasomotor symptoms. Overall low rates of menopause hormone therapy use suggest a need for education regarding hormone therapy, tailored to residential groups who rely on different resources on healthy aging.
- 17 December 2024
- Published by Wolters Kluwer Health in Menopause
- Vol. 32 (1) , 23-30
Menopause symptom burden and management across rural, suburban, and urban settings in a US population
Objective: The aim of this study was to compare menopause experience in rural, suburban, and urban-residing women. Methods: A 2019 online survey of US females queried respondents on menopause symptoms, resources, and treatments. Those ≥45 years of age and in late menopause transition or postmenopause were included in the analysis. Late menopause transition and postmenopause subgroups were stratified by rural, suburban, and urban residence, and age-weighted proportions for menopause symptoms and treatments were calculated and compared using chi-square tests. Results: A total of 1,531 respondents, 45% (n = 686) late menopause transition, mean age of 50.7 (SD 3.9) and 55% (n = 845) postmenopause, and mean age of 65.1 (SD 8.5) were included. More prevalent symptoms in late menopause transition rural residents were as follows: muscle aches and pains (urban: 49%, suburban: 49%, rural: 65%, P = 0.003), and panic attacks (urban: 18%, suburban: 24%, rural: 30%, P = 0.04). More prevalent symptoms in postmenopause rural residents were as follows: mood swings (urban: 18%, suburban: 14%, rural: 23%, P = 0.02), urinary incontinence (urban: 19%, suburban: 14%, rural: 23%, P = 0.02), and vaginal dryness (urban: 22%, suburban: 29%, rural: 37%, P = 0.004). Vasomotor symptom prevalence was high (71% late menopause transition, 20% postmeopause), but current menopause hormone therapy use was low (11% late menopause transition, 11% postmenopause) and did not differ by residence, despite differences in menopausal resources used. Conclusions: Rural women may experience greater burden of psychological and somatic menopause symptoms but not vasomotor symptoms. Overall low rates of menopause hormone therapy use suggest a need for education regarding hormone therapy, tailored to residential groups who rely on different resources on healthy aging.
- 1 April 2024
- Published by Wolters Kluwer Health in Menopause
- Vol. 31 (4) , 245-246
Finding SKYLIGHT for all: fezolinetant efficacy for vasomotor symptoms in subpopulations
- 1 April 2024
- Published by Wolters Kluwer Health in Menopause
- Vol. 31 (4) , 245-246
Finding SKYLIGHT for all: fezolinetant efficacy for vasomotor symptoms in subpopulations
- 29 November 2023
- Published by Wolters Kluwer Health in Clinical Obstetrics and Gynecology
- Vol. 67 (1) , 1-3
Foreword: Genitourinary Syndrome of Menopause
- 29 November 2023
- Published by Wolters Kluwer Health in Clinical Obstetrics and Gynecology
- Vol. 67 (1) , 1-3
Foreword: Genitourinary Syndrome of Menopause
- 16 July 2023
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 229 (4) , 425.e1-425.e16
Scholarly activity following National Institutes of Health Women’s Reproductive Health Research K12 training—a cohort study
- 16 July 2023
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 229 (4) , 425.e1-425.e16
Scholarly activity following National Institutes of Health Women’s Reproductive Health Research K12 training—a cohort study
- Top Cited Papers
- 14 April 2023
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 229 (1) , 39.e1-39.e12
Incidence, prevalence, and trends in polycystic ovary syndrome diagnosis: a United States population-based study from 2006 to 2019
- 14 April 2023
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 229 (1) , 39.e1-39.e12
Top Cited PapersIncidence, prevalence, and trends in polycystic ovary syndrome diagnosis: a United States population-based study from 2006 to 2019
- 8 November 2022
- Published by Wolters Kluwer Health in Menopause
- Vol. 29 (12) , 1351-1352
Susan D Reed, MD, MPH, MS, NCMP 2022-2023 NAMS President
- 8 November 2022
- Published by Wolters Kluwer Health in Menopause
- Vol. 29 (12) , 1351-1352
Susan D Reed, MD, MPH, MS, NCMP 2022-2023 NAMS President
- 20 September 2022
- Published by Wolters Kluwer Health in Menopause
- Vol. 29 (10) , 1119-1120
Increasing vasomotor symptoms: did your great grandmother really not feel them?
- 20 September 2022
- Published by Wolters Kluwer Health in Menopause
- Vol. 29 (10) , 1119-1120
Increasing vasomotor symptoms: did your great grandmother really not feel them?
- 2 June 2022
- Published by Elsevier in The Lancet
- Vol. 399 (10341) , 2103-2112
Intrauterine device-related uterine perforation incidence and risk (APEX-IUD): a large multisite cohort study
- 2 June 2022
- Published by Elsevier in The Lancet
- Vol. 399 (10341) , 2103-2112
Intrauterine device-related uterine perforation incidence and risk (APEX-IUD): a large multisite cohort study
- 1 June 2022
- Published by Wolters Kluwer Health in Menopause
- Vol. 29 (6) , 639-641
Dyspareunia—where and why the pain?
- 1 June 2022
- Published by Wolters Kluwer Health in Menopause
- Vol. 29 (6) , 639-641
Dyspareunia—where and why the pain?